ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Luye Pharma Group Ltd. ?
1
- OPERATING CASH FLOW(Y) Lowest at HKD 1,851.64 MM
- ROCE(HY) Lowest at 3.54%
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.32%
2
With ROE of 1.46%, it has a Very Expensive valuation with a 0.84 Price to Book Value
- Over the past year, while the stock has generated a return of 22.50%, its profits have risen by 115.6%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
44.52%
EBIT Growth (5y)
27.20%
EBIT to Interest (avg)
10.89
Debt to EBITDA (avg)
0.35
Net Debt to Equity (avg)
0.18
Sales to Capital Employed (avg)
0.11
Tax Ratio
11.47%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.67%
ROE (avg)
10.54%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
58
Industry P/E
Price to Book Value
0.84
EV to EBIT
52.14
EV to EBITDA
37.48
EV to Capital Employed
0.85
EV to Sales
5.84
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.63%
ROE (Latest)
1.46%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial TrendNot enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Luye Pharma Group Ltd.
Raw Material Cost
Fallen by 1.46% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at HKD 479.89 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Depreciation
At HKD 479.89 MM has Grown at 27.15%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Luye Pharma Group Ltd.
Operating Cash Flow
Lowest at HKD 1,851.64 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (HKD MM)
Net Sales
Lowest at HKD 3,240.18 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (HKD MM)
Net Profit
Fallen at -69.74%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
EPS
Lowest at HKD 0.02
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (HKD)
Inventory Turnover Ratio
Lowest at 2.32%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 1.73%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
